ATAP Advocates
Taking a Stand For Patients

ATAP News

News Updates

Dr. Robert Levin Discusses Reforming Drug Pricing Policy

During this 28 minute conversation, Dr. Levin discusses ATAP's mission and funding and ATAP's position on the administration's current proposal to reform Medicare Part B drug pricing via reference pricing or via the use of an international price index.  Dr. Levin discusses moreover the administration's current proposal to reform Medicare Part D drug pricing by eliminating or prohibiting drug manufacturers from paying a rebate to pharmaceutical benefit managers (PBMs) and Part D plan sponsors.  This conversation concludes with Dr. Levin's comments concerning the long standing debate whether the Secretary of DHHS should be allowed to negotiate Part D drug prices with manufacturers.  

Read More
Barbara Arnago
Commentary by Dr. Robert Levin: Pharmacy benefit managers can still game the system despite Senate attempt to close Medicaid loophole

On Dec. 4, Senators Chuck Grassley (R-Iowa) and Ron Wyden (D-Ore.) introduced new legislation to ensure that drug companies play by the rules of the Medicaid program. The bill is aimed at preventing drug companies from overcharging Medicaid, a practice that has been consistently costing taxpayers billions of dollars. While the legislation is an excellent indicator of future bipartisan cooperation on the issue of prescription drug affordability, much more needs to be done.

Read More
Barbara Arnago
Letter to the editor: Sen. Collins is part of large effort to lower cost of prescriptions

In his Sept. 25 article, “Collins’ bills to ban pharmacy ‘gag clauses’ pass House and Senate,” Staff Writer Joe Lawlor reported that the Patient Right to Know Drug Prices Act – sponsored by Maine Republican Sen. Susan Collins – had been approved by both houses of Congress, along with the Know the Lowest Price Act. On Oct. 10, President Trump signed these bills into law.

Read More
Barbara Arnago
Commentary by Dr. Robert Levin: Gag clauses keep patients in the dark about overpriced prescriptions

In March, Sen. Susan Collins, R-Maine, introduced the Patient Right to Know Drug Prices Act. Backed by a bipartisan group of lawmakers, the bill bans the “gag clauses” that prevent pharmacies from informing consumers whether they could spend less on their medication by paying the full price for an identical product produced by a different manufacturer.

Read More
Barbara Arnago